REVIVE study: a prospective observational study in chemotherapy after nivolumab therapy for advanced gastric cancer

Nivolumab is an increasingly used standard care treatment for heavily pretreated patients with advanced gastric cancer, with increasing clinical use in Japan. Data from retrospective studies on various tumors have shown the objective response rate to cytotoxic chemotherapy potentially improves after...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Future oncology (London, England) England), 2021-03, Vol.17 (8), p.869-875
Hauptverfasser:	Narita, Yukiya, Shoji, Hirokazu, Kawai, Sadayuki, Mizukami, Takuro, Nakamura, Michio, Moriwaki, Toshikazu, Yamanaka, Takeharu, Sunakawa, Yu, Kawakami, Hisato, Nishina, Tomohiro, Misumi, Toshihiro, Muro, Kei
Format:	Artikel
Sprache:	eng
Schlagworte:	cytotoxic chemotherapy gastric cancer immune checkpoint inhibitor nivolumab
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!